Process evaluation of co-designed interventions to improve communication of positive newborn bloodspot screening results by Chudleigh, Jane et al.




Process evaluation of co-designed 
interventions to improve 
communication of positive newborn 
bloodspot screening results 
 
J. Chudleigh, P. Holder, L. Moody, A. Simpson, K. Southern, S. Morris, F. Fusco, F. Ulph, M. 
Bryon, J.R. Bonham, and E. Olander 
 
Final Published Version deposited by Coventry University’s Repository 
 
Original citation & hyperlink:  
Chudleigh, J., Holder, P., Moody, L., Simpson, A., Southern, K., Morris, S., Fusco, F., Ulph, 
F., Bryon, M., Bonham, J.R. and Olander, E., 2021. Process evaluation of co-designed 
interventions to improve communication of positive newborn bloodspot screening results. BMJ 








© Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY. 
Published by BMJ. https://creativecommons.org/licenses/by/4.0/This is 
an open access article distributed in accordance with the Creative 
Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits 
others to copy, redistribute, remix, transform and build upon this work 
for any purpose, provided the original work is properly cited, a link to the 
licence is given, and indication of whether changes were made. 
See: https://creativecommons.org/licenses/by/4.0/. 
1Chudleigh J, et al. BMJ Open 2021;11:e050773. doi:10.1136/bmjopen-2021-050773
Open access 
Process evaluation of co- designed 
interventions to improve 
communication of positive newborn 
bloodspot screening results
Jane Chudleigh   ,1 Pru Holder,1 Louise Moody,2 Alan Simpson,3,4 
Kevin Southern,5 Stephen Morris   ,6 Francesco Fusco,7 Fiona Ulph,8 
Mandy Bryon,9 James R Bonham,10 Ellinor Olander1
To cite: Chudleigh J, 
Holder P, Moody L, et al.  
Process evaluation of co- 
designed interventions to 
improve communication of 
positive newborn bloodspot 
screening results. BMJ Open 
2021;11:e050773. doi:10.1136/
bmjopen-2021-050773
 ► Prepublication history and 
additional supplemental material 
for this paper are available 
online. To view these files, 
please visit the journal online 
(http:// dx. doi. org/ 10. 1136/ 
bmjopen- 2021- 050773).
Received 01 March 2021
Accepted 13 August 2021
For numbered affiliations see 
end of article.
Correspondence to
Dr Jane Chudleigh;  
 j. chudleigh@ city. ac. uk
Original research
© Author(s) (or their 
employer(s)) 2021. Re- use 
permitted under CC BY. 
Published by BMJ.
ABSTRACT
Objective To implement and evaluate co- designed 
interventions to improve communication of positive 
newborn bloodspot screening results and make 
recommendations for future research and practice.
Design A process evaluation underpinned by 
Normalisation Process Theory.
Setting Three National Health Service provider 
organisations in England.
Participants Twenty- four healthcare professionals (7 
newborn screening laboratory staff and 24 clinicians) and 
18 parents were interviewed.
Interventions Three co- designed interventions were 
implemented in practice: standardised laboratory 
proformas, communication checklists and an email/letter 
template.
Primary outcome measures Acceptability and feasibility 
of the co- designed interventions.
Results Auditing the implementation of these 
interventions revealed between 58%–76% of the items 
on the laboratory proforma and 43%–80% of items on the 
communication checklists were completed. Interviews with 
healthcare professionals who had used the interventions 
in practice provided positive feedback in relation to the 
purpose of the interventions and the ease of completion 
both of which were viewed as enhancing communication 
of positive newborn bloodspot screening results. 
Interviews with parents highlighted the perceived benefit 
of the co- designed interventions in terms of consistency, 
pacing and tailoring of information as well as providing 
reliable information to families following communication 
of the positive newborn bloodspot screening result. 
The process evaluation illuminated organisational and 
contextual barriers during implementation of the co- 
designed interventions in practice.
Conclusion Variations in communication practices for 
positive newborn bloodspot screening results continue 
to exist. The co- designed interventions could help to 
standardise communication of positive newborn screening 
results from laboratories to clinicians and from clinicians 
to parents which in turn could improve parents’ experience 
of receiving a positive newborn bloodspot screening result. 
Implementation highlighted some organisational and 
contextual barriers to effective adoption of the co- designed 
interventions in practice.
Trial registration number ISRCTN15330120.
INTRODUCTION
Each year in England, almost 10 000 parents 
are informed of their child’s positive 
newborn bloodspot screening (NBS) result 
around 2–8 weeks, depending on the condi-
tion, after birth.1 2 NBS currently includes 
nine conditions; sickle cell disease (SCD); 
cystic fibrosis (CF); congenital hypothy-
roidism (CHT); phenylketonuria (PKU); 
medium- chain acyl- CoA dehydrogenase defi-
ciency (MCADD); maple syrup urine disease 
(MSUD); isovaleric acidaemia (IVA); glutaric 
aciduria type 1 (GA1); and homocystinuria 
(HCU) (pyridoxine unresponsive) – the 
latter six collectively referred to as inherited 
metabolic diseases (IMDs).
Strengths and limitations of this study
 ► This is the first known study that has used co- 
designed interventions to improve communication 
of positive newborn bloodspot screening results.
 ► Healthcare professionals involved in the present 
study were employed in three different National 
Health Service organisations, increasing transfer-
ability of the findings.
 ► Healthcare professionals were recruited via email; 
those with a pre- existing interest in this topic may 
have been more likely to self- select into the study. 
These may also communicate results differently 
than providers who did not participate in the study.
 ► The study included healthcare professionals involved 
in managing, and parents of children diagnosed 
with, one of the nine conditions currently included 
in the newborn bloodspot screening programme in 
England; previous work has mainly focused on cys-
tic fibrosis and sickle cell disease.
 ► COVID-19 hindered implementation of the co- 
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Communicating positive NBS results is not an event but 
a process that starts from the moment the result is iden-
tified by the NBS laboratory (NBSL) as being above the 
agreed analytical ‘cut- off’ and ends when the parents are 
given the definitive diagnosis for their child.3 The clinical 
spectrum in screen positive cases varies enormously and 
consequently the message to parents needs to be carefully 
crafted to prepare for a range of outcomes; communi-
cation of positive NBS results is a subtle and skilful task 
which demands thought, preparation and evidence to 
minimise potentially harmful negative sequelae.4–8
Guidance regarding the content and best mode of 
communication between healthcare professionals (HCPs) 
and parents is variable for the different screened condi-
tions9 10 and is often not evidence- based. Studies have 
shown that receiving a positive NBS can make parents feel 
anxious and stressed6 11–14 and that the knowledge of the 
HCP and the approach used can help alleviate this13–15 
Parents who were dissatisfied with the initial information 
often complained about a lack of explanation for the 
test result or that information was superficial.12 It is clear 
that parental information needs are variable and that 
improvements are needed.11 13
Poor, or inappropriate, communication strategies for 
positive NBS results can influence parental outcomes in 
the short term4–7 11–13 but may also have a longer- term 
impact on children and families.8 16 Therefore, exploring 
strategies that can alleviate distress associated with the 
initial communication of a positive NBS result is crucial 
to improving parents’ experiences.
Existing evidence supports the importance of ensuring 
the initial communication of positive NBS results is 
handled sensitively, considers individual parent charac-
teristics, to minimise parental distress and consequences 
of this distress as well as the knowledge and experience of 
the person imparting the result. However, to date, while 
studies have explored experiences of receiving positive 
NBS result and strategies for improving communica-
tion,6 7 17 18 no studies have focused on designing imple-
menting or evaluating such strategies in practice. The 
purpose of the current study was to implement and eval-
uate three interventions to improve communication of 
positive newborn bloodspot screening results and make 
recommendations for future practice and research. The 
interventions were co- designed by parents and HCP; this 
is described elsewhere.19
METHODS
Experience- based co- design20 was used to develop co- de-
signed interventions to improve communication of 
positive NBS result to families.21 A process evaluation 
underpinned by Normalisation Process Theory (NPT)22 23 
was used to study the implementation and assimilation 
of the co- designed interventions into routine practice as 
part of a larger programme of work.3 21 24 These included: 
a standardised laboratory proforma for communication 
of positive NBS results from the NBSLs to clinicians; 
standardised communication checklists for communica-
tion of positive NBS results to the family; and a letter/
email template for providing information to the family 
immediately after communication of the initial NBS 
result. Staff in each study site were able to choose from 
a variety of training options including face- to- face (in 
person or remotely) individual or group training (this 
was condition specific to ensure the correct interven-
tions were presented to the relevant staff) via narrated 
PowerPoint presentations and/or annotated PowerPoint 
presentations. These training materials were also made 
available on the study blog. Success criteria (figure 1) 
were defined to ensure that implementation of the co- de-
signed interventions was acceptable and feasible.
Patient and public involvement
Patient and public involvement (PPI) was fundamental 
to the design and conduct of this study. Eight parents of 
babies who had received a positive NBS screening result 
for one of the nine screened conditions formed a PPI advi-
sory group who met prior to, during and following data 
collection. Their suggestions were incorporated into the 
study design, the data collection tools and the data anal-
ysis and presentation. The PPI group were presented with 
data from the annual reports of the NBS programmes and 
made suggestions as to which sites should be used for the 
implementation phase of the work. Initial findings were 
presented to members of the PPI group during regular 6 
monthly meetings. In addition, we obtained the views of 
representatives from charities for the screened conditions 
including Metabolic Support UK, the British Thyroid 
Foundation, the CF Trust and the Sickle Cell Society.
Setting
The interventions were introduced into three National 
Health Service (NHS) provider organisations in England 
(the study sites) served by two NBSLs that had been 
involved in the co- design process.19
Figure 1 Success criteria for implementing the co- designed 
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Inclusion and exclusion criteria
In order to explore the actual and perceived usefulness 
of the co- designed interventions, parents who had been 
given their child’s positive NBS result during the previous 
12 months for whom the co- designed interventions had 
and had not been used were included. This enabled us to 
explore if the perceived perspectives and actual experi-
ences of the interventions were comparable.
NBSL staff involved in processing NBS samples and 
clinicians including consultants and nurses special-
ists involved in communicating positive NBS results in 
the previous 6 months, were invited to take part in the 
study. HCPs (NBSL staff and clinicians) who had not 
been involved in NBS in the last 6 months or who had 
personal experience of receiving a positive NBS result 
were excluded.
Recruitment and sampling
HCPs were sampled purposively based on their experi-
ence with the phenomena of interest, that is, they had 
used the co- designed interventions in practice. HCPs 
provided all parents who had experienced the interven-
tions with an information sheet about the study and asked 
if they could share their details with the research team. 
Once the details were received, parents were contacted by 
the research team and invited to participate in the study. 
In addition, a purposeful sample of parents who had 
received a positive NBS result without the co- designed 
interventions were also identified by HCPs. Written 
informed consent was obtained from all participants.
Data collection
Following training with HCPs in each of the study sites, 
the co- designed interventions were implemented in 
March 2020 and then following a pause due to COVID-
19, from September to December 2020.
Audit of completion of co-designed interventions
The fidelity of the co- designed interventions was assessed 
in the three NHS Trusts. Staff were asked to send the 
research team all completed laboratory proformas and 
communication checklists so these could be audited in 
terms of accuracy and completeness. These were redacted 
to maintain patient confidentiality.
Semi-structured interviews
HCPs were invited to take part in semi- structured inter-
views to ascertain their views regarding the acceptability, 
feasibility and usability of the co- designed interven-
tions following implementation. The interview ques-
tions (online supplemental file A) were based on those 
proposed by the developers of the NPT approach22 22 23 23 
and the success criteria (figure 1). The purpose was to 
explore the views of the interventions and perceptions of 
factors that were influential (mechanisms of impact and 
context).25
Parents who had received a positive NBS screening 
result both with and without the co- designed interven-
tions were also invited to take part in semi- structured 
interviews to ascertain their experiences and perceptions 
of the co- designed interventions, respectively (online 
supplemental file B).
Data analysis
Audit of completion of co-designed interventions
Accuracy and completeness of the co- designed interven-
tions was audited; percentages were calculated for each 
item.
Semi-structured interviews
All interviews were audio- recorded and transcribed 
verbatim. Interviews undertaken with HCPs were subject 
to framework analysis.26 Success criteria (figure 1) were 
developed using NPT22 23 and provided the framework for 
analysis of these data. In the first stage (familiarisation), 
two members of the research team (JC and PH) familia-
rised themselves with the data by reading the interview 
transcripts. In stage 2 (developing a theoretical frame-
work), key, recurring themes in the same interview tran-
script were compared with the a priori success criteria 
(figure 1) by the same two members of the research 
team. In stage 3 (indexing) two members of the research 
team (JC and PH) coded data from a further two inter-
views while identifying relevant participant quotes for 
the identified themes/subthemes from each interview. 
These were compared and 90% intercoder reliability was 
achieved. In stage 4 (charting) the same two members of 
the research team agreed on a final framework with four 
subthemes and data were summarised in a thematic chart 
in an Excel spreadsheet. In the final stage (synthesising) 
the two members of the research team created a summary 
of the main descriptive comments and developed an 
explanatory account.
Interviews with parents were analysed thematically; an 
inductive approach to data analysis was used and themes 
generated using a latent approach to provide a deeper 
understanding of opinions regarding the proposed inter-
ventions.27 Two members of the research team (JC and 
PH) coded one interview transcript separately. These 
codes were then compared with inform and align code 
development28 and a code book was developed.29 A 
further two transcripts were then coded separately by 
the same two members of the research team using the 
code book. These separately coded transcripts were then 
compared; intercoder reliability was 87%. Following this, 
the remainder of the transcripts were divided between 
the same two members of the research team. This was an 
ongoing, iterative process; new codes were developed and 
the definition of codes refined as analysis progressed. Any 
proposed changes to the code book were discussed where 
relevant after each interview transcript had been analysed 
to ensure consensus; the final version of the code book 
(V.3) was developed after a further three transcripts had 
been analysed. Once coding had been completed, all data 
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Positionality and reflexivity
Members of the study team (JC, JRB, LM, FU, MB and 
KS) have been involved in or continue to undertake 
a variety of roles and activities associated with the NBS 
programme in the UK. It is acknowledged that this could 
have led to potential bias during data collection and anal-
ysis. However, this was balanced by other members of the 
research team who had previously had minimal involve-
ment in NBS (EO, AS, SM, FF and PH). Data collection 
and analysis was mainly undertaken by JC and PH who fall 
within both camps. Neither JC nor PH were employed in 
the organisations where data collection was undertaken.
RESULTS
Training
Training for the implementation of the co- designed inter-
vention was undertaken with 23 staff in study site 1, 9 staff 
in study site 2 and 14 staff in study site 3. Forty- one staff 
were trained during face- to- face sessions and five were 
trained online. Staff were asked to provide feedback at 
the end of the training sessions using a 5- point Likert 
scale consisting of statements ranked from strongly agree 
to strongly disagree. Twenty- nine staff (63%) provided 
feedback. These were scored numerically so that strongly 
agree was awarded a score of 5 and strongly disagree was 
awarded a score of 1; a score of 3 would therefore have 
indicated a neutral response, a score over 3 would indi-
cate positive feedback and under 3 would indicate nega-
tive feedback. Responses ranged from 4.3 to 4.6 (median 
4.5).
Staff interviews
Thirty- one HCPs were approached across the three study 
sites (7 NBSL staff and 24 clinicians); 24 were interviewed 
(median 27.1, range 10.59–57.2 min). Seven were inter-
viewed from Site 1 (four did not respond to the invita-
tions); nine were interviewed from Site 2 (all responded 
to invitations) and eight were interviewed from Site 3 
(three did not respond to invitations). This is summarised 
in box 1.
Interviews with parents
Twelve parents (seven from Site 1, four from Site 2 and 
one from Site 3) who had received a positive NBS result 
but who had not experienced the interventions were 
interviewed (median 29.4, range 16.5–36.4 min), none 
of those approached declined. Eight parents who had 
received a positive NBS result and had experienced the 
interventions were approached, six were interviewed 
(median 28.5, range 15.4–43.3 min). Two parents from 
study Site 1 did not respond to arranged telephone calls 
and consequently were not interviewed. Those inter-
viewed consisted of two parents from Site 1 who had a 
child with PKU and four from Site 3 who had children 
with CF. This is summarised in table 1. Interview responses 
from parents who had experienced the interventions are 
denoted by (+), and parents who had not experienced the 
interventions by (–).
Intervention fidelity
Two NHS Trusts (Sites 2 and 3) were served by one 
NBSL which had implemented the co- designed labora-
tory proformas. The other, Site 1 was served by the other 
NBSL and had only implemented the proforma for CF 
and had therefore only completed the form on one occa-
sion. Feedback was therefore sought from staff in all three 
Trusts but for the latter, this focused on exploring any 
challenges they had experienced which had led to them 
not fully implementing the co- designed interventions in 
order to determine potential barriers.
Two clinical teams in Site 1 (metabolic and CHT) and 
one clinical team in Site 3 did not implement the co- de-
signed interventions; feedback was still sought from these 
to determine any barriers to implementation; one team 
in Site 1 did not respond.
Seventy completed laboratory proformas and 16 
communication checklists were provided by the study 
sites. The NBSL that served Sites 2 and 3 chose to adopt 
the proforma from March to December 2020, and were 
Box 1 Staff interviews
Site 1: n=7
1 NBSL staff, 6 clinicians (2×IMD, 2×SCD, 2×CF)
Site 2: n=9
3 NBSL staff, 6 clinicians (2×IMD, 4×CHT)
Site 3: n=8
1 NBSL staff, 7 clinicians (3×SCD, 4×CF)
CF, cystic fibrosis; CHT, congenital hypothyroidism; IMD, inherited metabolic 
disease; NBSL, newborn bloodspot screening laboratory; SCD, sickle cell 
disease.
Table 1 Interviews with parents
Parents who had received: Site and condition
A positive NBS result but had not 
experienced the interventions, 










A positive NBS result and had 
experienced the interventions, n=6 





CF, cystic fibrosis; CHT, congenital hypothyroidism; IVA, 
isovaleric acidaemia; MCADD, medium- chain acyl- CoA 
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therefore able to provide completed proformas for a 
9- month period. The other NBSL and clinicians in all 
sites, only collected data using the proforma and check-
lists during March 2020 and then September–December 
2020; this is reflected in the number of proformas and 
checklists returned for each site in table 2.
The NBSLs completed between 58%–76% of the items 
on the first page of the laboratory proforma. The most 
common items not completed on the laboratory proforma 
included: the case/laboratory ID; the designation of the 
person making the referral; legacy names (CF); haemo-
globin S (HbS) mutations (SCD); General Practitioner 
(GP) phone number; results of other conditions included 
in NBS; and feedback from the clinical team. The second 
page, which contained further information about the 
NBS test results and a checklist regarding completion of 
the referral process was not completed indicting a lack 
of fidelity for this section of the intervention. Clinicians 
indicated that reducing the length of the laboratory 
proforma so it fitted on one side of paper for ease of 
completion would be preferable.
NBSL, Site 2, Participant 1: It’s good to try and keep 
them on one A4 piece of paper if possible…case lab-
oratory ID stuff is on the second page. We don’t need 
that…we can get that from our [IT system].
The original objective of the study was to produce a 
checklist for communication of the initial positive NBS 
result. However, during the co- design phase, clinicians 
in the study sites and parents indicated they would like 
a series of checklists that catered for all communication 
around the positive NBS result. Therefore, separate 
checklists were developed for the initial communica-
tion, the initial clinical visit and subsequent clinical visits. 
However, most clinicians consistently chose to only use 
the checklists for the initial communication. Therefore, 
data in table 2 is only presented for this section of the 
co- designed intervention. Completion ranged from 
43%–80%. The most common items not completed on 
the initial communication checklist included: diagnosis 
date/age; weight; gene mutations (SCD); GP details; 
health visitor details; summary information from the first 
contact. Therefore, while in theory staff favoured the idea 
of having more information in one place about the child 
and family, this was not borne out in practice. This was 
supported by the interview data; some staff questioned 
the usefulness of the checklists for the first and subse-
quent clinical visits.
Clinician 1, Site 2: I like the initial consultation bit, or 
the first visit bit. I like that bit but I have to say I don’t 
really use much of the rest of the pages.
However, other clinicians indicated that having all of 
the information together regarding communication with 
parents following a positive NBS result was useful.
Clinician 1, Site 3: I think it’s useful for the clinician 
to know what they've said last time and build on that 
information the next time they see them and then it’s 
useful when they end up seeing someone completely 
different to be able to look back and just remind par-
ents it’s already been covered but let’s go through it 
again. You know, I think it’s quite a good prompt for 
people to be systematic about the information they 
give out.
Implementation of the interventions
Three themes were identified in relation to the imple-
mentation of the laboratory proforma and the commu-
nication checklists: Coherence of the intervention; 
compatibility and resource use; and ease of completion 
and layout. The first two themes were also applicable in 
relation to the email/letter to parents.
Laboratory proforma
Coherence of the intervention
Staff in the NBSL that served Sites 2 and 3 and who had 
fully implemented the interventions felt that the project 
intentions were positive and they improved current 
processes. Consequently, they were keen to implement 






Average (range) % complete
Side 1 Side 2
Site 1
CF 1 69 (N/A) 0
Site 2
CF 18 69 (62–77) 0
CHT 36 75 (61–82) 0
GA1 1 67 (N/A) 0
IVA 1 76 (N/A) 0
MCADD 2 68 (64–73) 0
PKU 8 62 (56–84) 0
Site 3
SCD 3 58 (54–58) 19
Checklists for initial communication of positive NBS result
Condition No. completed Average % complete
Site 1
MCADD 1 80 (N/A)
PKU 1 68 (N/A)
SCD 1 76 (N/A)
Site 2
CHT 2 72 (66–78)
PKU 4 43 (32–68)
Site 3
CF 7 57 (35–87)
CF, cystic fibrosis; CHT, congenital hypothyroidism; GA1, glutaric 
aciduria type 1; IVA, isovaleric acidaemia; MCADD, medium- chain 
acyl- CoA dehydrogenase deficiency; NBS, newborn bloodspot 
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the laboratory proformas during the study period and 
keep using the proformas once the study had ended.
In addition, feedback from this NBSL (Sites 2 and 3) 
suggested that they included more information than the 
previous forms they had been using which was viewed 
favourably.
NBSL, Site 2, Participant 3: I think they’re better 
from the point of view that it tries to capture more 
information than we used to have. Especially for the 
carriers and stuff…I can see the difference when I 
go to fill in one of the carrier ones or one of the old 
expired ones.
Furthermore, in relation to CHT, staff in this NBSL 
felt that the study proformas would help clinicians who 
were not based in tertiary centres to understand the next 
steps in the process for these babies. This also meant the 
NBSL staff felt more confident that the babies would be 
followed up appropriately.
NBSL, Site 2, Participant 1: My concern always, again, 
going back to CHT, is that the person who we give 
the result to may not always have the knowledge avail-
able of what to do next. Having that checklist for 
them about what they’re meant to do…It’s useful for 
them, especially if their consultant’s not present…we 
didn’t really put a checklist in our referrals before for 
CHT…that checklist will help most locum paediat-
ric registrars who we refer the result to, to give them 
some guidance what to do next.
Staff in the same NBSL felt that having standardised 
national laboratory proformas would be useful if NBSL 
staff or clinicians moved from one site to another as they 
would already be familiar with the processes used.
NBSL, Site 2, Participant 2: I think that would be re-
ally advantageous. I think it’s meant to be a national 
screening programme and we are meant to do the 
same thing, we’re meant to follow the same proto-
cols. And if we use the same paperwork, we would 
make our lives easier, we would make people moving 
between labs, people moving between clinical teams, 
any of the above in the screening pathway, would 
simplify it for them if everybody was doing the same 
thing.
The other NBSL (Site 1) was not aware that other labo-
ratories were using different forms to refer positive NBS 
results to clinical teams and therefore could not see the 
purpose of the intervention.
NBSL, Site 1, Participant 1: I naively assumed that 
every lab was using the national templates that have 
been recommended and are in all the lab guides. So, 
I don’t know why this has been reinvented, really.
This site (Site 1) had only implemented the labora-
tory proformas for one condition and stated that as they 
were very similar to their existing processes, they did not 
understand the rationale for the proposed changes and 
felt they would take too long to implement.
Compatibility and resource use
Difficulties in terms of operationalising standardised 
processes were raised due to individual NBSLs following 
different processes:
NBSL, Site 2, Participant 3: Each lab, even though 
we follow the same standards, the same guidelines, 
there’s always a different way of doing things, and so 
what’s inconsequential to one lab may seem conse-
quential, but then my take on this is if you’ve got elev-
en labs doing it one way and the twelfth lab is doing it 
a completely different way then, the other lab should 
in theory get in line, because eleven labs are doing it 
all the same way.
This was linked to similar concerns regarding how 
the laboratory proformas would fit into the different 
computer systems that were being used nationally by 
different NBSLs. However, a proposed solution involved 
changing processes so the standard proformas get auto-
matically populated form the existing computer system to 
avoid transcription errors.
For Sites 2 and 3 (served by one NBSL) that had fully 
implemented the laboratory proformas, it was acknowl-
edged that using a different form was initially more time 
consuming which could act as a barrier to implementa-
tion. However, feedback suggested once familiar with the 
layout of the form, this resolved quite quickly:
NBSL, Site 2, Participant 3: At the beginning you may 
find it a little bit, I don’t know, scary, or it will take 
more time but after doing quite a lot it’s alright.
Also, that this was offset by the fact that the study 
proformas allowed all the required information to be 
collated in one place which had the potential to save time 
in the long run.
NBSL, Site 2, Participant 3: As a lab person, it makes 
me having sort of a lot of information of the day to-
gether so I don’t have to look here and there. Like 
let’s look at the card, let’s look at the referral letter, 
let’s look at this and that. And I think the clinicians 
should be happier because they have them all togeth-
er. Definitely in terms of the lab, I felt that it’s much 
more informative than the ones we had.
This view was shared by clinicians who had received 
the laboratory proformas who fed back that the labo-
ratory proformas had been time saving and helpful in 
terms of sharing information and reducing the number 
of resources they needed to consult to gather information 
about the family.
Clinician 1, Site 3: We’re not opening lots of attach-
ments to find the information we need, it’s all there 
in one place which is good…I quite like this actually. 
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Ease of completion and layout
Feedback suggested that the layout of the laboratory 
proformas made them easy to use in practice. However, 
there were some boxes that the NBSL identified were 
labelled slightly differently in terms of terminology than 
the laboratories were used to and therefore it was recom-
mended that these could be changed. Furthermore, one 
of the sites also raised queries about who was responsible 
for completing certain parts of the laboratory proforma 
and thought this could be made more explicit. Conse-
quently, study sites also made recommendations for minor 
changes to the proformas such as combining sections to 
avoid duplication.
NBSL, Site 3, Participant 1: It’s, kind of, knowing 
what you want filled in when by which person, which 
lab or other parties, so that whoever’s using the form 
is aware which ones they're filling in.
Communication checklists
Coherence of the intervention
Clinicians viewed the purpose of the communication check-
list as multifaceted. Similar to the laboratory proformas, 
many clinicians indicated that standardising commu-
nication nationally would be advantageous in terms of 
improving communication with families of children with 
positive NBS results.
Clinician 1, Site 1: For us, this is our patient’s journey. 
We want the best experience for them and we want to 
make sure that every family have the same experience 
and, you know, the same information. So, for us to 
standardise something, I think, is crucial.
This view was also shared by parents who had not expe-
rienced the interventions. These parents were aware that 
practices differed throughout the country with regard to 
how positive NBS results were communicated to parents 
and were keen for this to be remedied:
Site 1, Mother, MCADD–: More consistent across the 
UK. That would be great, wouldn’t it? That everybody 
has the same consistent, great support right from the 
beginning.
Parents who had experienced the interventions also 
thought the checklists were reassuring.
Site 1, Father, PKU+: Yes, checklists are good aren’t 
they. I do like a checklist to be honest. But, yes, they 
are very easy, simple. …a checklist is easier, you see it 
in full, it’s explanatory and it’s reassuring.
Parents who had not experienced the interventions also 
stated they would reduce inconsistency and ensure parity 
in terms of the experience parents had of receiving their 
child’s positive NBS result.
Site 1, Father, PKU–: A checklist is a checklist regard-
less of what industry, what religion, what education 
you are isn’t it…so I don’t see any reason why, it’s not 
like you’re asking someone to log on to a computer 
and talking a different language or, you know, work 
out some kind of maths equation, it’s simple, stan-
dard, uniform process across the world, a checklist.
It was also felt that using the checklists could be helpful in 
terms of facilitating communication both within and across 
clinical teams. The former referred to the family seeing 
different team members during clinic visits.
Clinician 2, Site 3: I think it’s a useful thing because 
we try to stick to the same consultant for the first few 
visits at least, so there’s some continuity. But that 
can’t always be guaranteed, if you’re going on holi-
day…it’s really helpful to have the tick box to say that 
this is covered, that’s covered, because there are gaps 
of things that have not been covered, then you know 
that you can address them, you know, when you see 
them. I think it is helpful, yes.
Others clinicians felt that standardisation was not always 
possible or desirable due to the need to accommodate 
parental reactions and tailor information accordingly; 
thus, highlighting the perceived importance of the skills 
and attributes of the person communicating the result. 
However, it was acknowledged that it was still important that 
certain pieces of information were communicated to fami-
lies and the communication checklist could help with that.
Clinician 3, Site 2: I think it’s too nuanced and 
complicated and different families need different 
things. I don’t think it’s the sort of thing you can re-
ally standardise, whereas our initial contact is, by its 
very nature, pretty structured. You’ve got a very small 
amount of time and it’s just a phone call, and you’re 
focussed on the really important bits of information 
to get the family in and give them the basic kind of 
information.
Nevertheless, the same clinician thought the check-
lists would be useful for new members of staff, nurses and 
doctors, who may be less familiar with processes and proce-
dures. Other benefits included acting as an aide memoir 
and improving accountability.
Clinician 1, Site 1: We see families and we have lots 
of conversations, but we don’t actually always docu-
ment what we talk about. And actually, from an ac-
countability point, we probably should. So, actually 
it’ll probably make us work better.
Furthermore, parents who had experienced the commu-
nication checklist indicated that separating information in 
terms of what needed to be covered in the initial communi-
cation, the first clinical appointment and subsequent visits 
would also be preferable to avoid overloading them with 
information.
Site 1, Mother, PKU+: I think what would have helped 
me is just have it in more of a section of, right, from 
nought to six months this is what you need to fo-
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brackets are. Just because, we were asking questions 
about how it’s going to affect [baby] when she’s twen-
ty. And on that day, at that moment, you probably 
do worry about all that stuff, but it needed just to be 
said, ‘Right, calm down, let’s just focus on the next 
six months, and this is what it’s going to look like’.
Parents who had not experienced the interventions 
shared similar feelings and felt that using a checklist could 
be beneficial from a HCP perspective to help with pacing 
and tailoring information to families. For some, this meant 
that it would avoid repetition.
Site 1, Father, MCADD–: At least then they’re not re-
peating themselves to us, and we’re not asking the 
same questions, they’re not asking the same ques-
tions of us.
For others, this meant that concepts that they had found 
difficult could be revisited:
Site 1, Father, PKU–: In the early days of having it, 
repetition is kind of healthy, it reinforces our knowl-
edge of it, like I say my memory is terrible so, you 
know, hearing the doctors saying it to me a few times 
is pretty handy.
Compatibility and resource use
Clinicians who had not used the communication check-
lists indicated that other potential barriers to using them 
included personal preference, clinical experience and 
knowing what to tell parents already. One participant 
in particular called the checklist ‘a bit redundant and…
moderately insulting’ Clinician 3, Site 3. This manifested in 
a reluctance to move away from a system they were comfort-
able and familiar with.
Clinician 3, Site 1: It feels like a tick box exercise 
for me. So that’s my challenge, is that, and I don’t 
use them in a way that probably somebody that was 
new would use them because they would probably be 
more rigid at going through and making sure they 
had understood all those things. Whereas I, sort of, 
already know the key things that I have got to cover 
and I do cover them. So, it’s more paperwork for me 
to do/fill.
In terms of time needed to implement the interventions, 
opinions of clinicians were divided. Those who had not 
implemented the interventions anticipated them taking 
more time to complete than current processes. However, 
those who had used the co- designed interventions in prac-
tice indicated they had taken less time than their current 
processes.
Clinician 4, Site 3: I think it [communication check-
list] just makes it a bit more streamlined. It’s definite-
ly not made it longer …these ones have been quicker.
Reasons for not using the interventions were also 
explored which highlighted the importance of perceived 
gatekeepers buying into the proposed changes and their 
influence on others even if they did not share the same 
view. This included staff instructing others not to use the 
checklists as they were seen as a ‘tick box exercise’.
Clinician 1, Site 1: The initial push- back from [mem-
ber of staff] was that it’s a checklist and we see them 
in the person, and we don’t have the paperwork out 
and go, ‘Tick, tick, tick.’ But actually, you’re sitting at 
a computer now and not doing home visits. So, you 
should be using this. You’ve got no excuse.
Concern was also raised with regard to what would 
happen with the checklists following communication of 
the positive NBS result and who the information would 
be shared with.
Clinician 3, Site 3: [The proforma and checklists] 
contain a lot of patient information and addresses 
and dates of birth, and it’s all personal information 
that has to be stored properly and securely, and you 
have to, I guess, think what the form’s for and what 
are you going to do with it?… It’s not clear who would 
want to see it in the future, where you would file it, 
what it’s for, who it would help.
Other clinicians had already considered this issue 
and stated it would be useful to have the checklist at the 
front of the child’s medical notes which would be stored 
according to hospital policy and therefore be compliant 
with General Data Protection Regulation (GDPR) 
requirements.
Ease of completion and layout
Clinicians expressed mixed feelings about completing the 
checklists; these were generally divided into those who 
had used them and those who had not. Some clinicians 
who had implemented the communication checklists had 
experimented with how best to use them in practice.
Clinician 4, Site 2: I think what I did the very first 
time I used it, I did my spiel and then I went through 
and said, ‘Oh, actually, did I mention that-,’ I think 
there were, like, a couple of things that I hadn’t said, 
maybe, ‘Have you got a question that you want to 
write down?’ or something like that. I might not have 
thought to offer them. So, it was useful to have. And 
then, I think, the second time I did it I just followed 
your pro forma specifically as opposed to doing my 
usual one, and then, I think, I maybe just expanded 
bits that I wanted to.
Others indicated that they had used the checklists from 
the outset and had found them logically presented and 
a useful prompt for the topics that they needed to cover 
during their conversations with parents. This view was 
shared by parents who had experienced the communi-
cation checklists. Parents indicated that they liked the 
succinct, straightforward nature of this when it had been 
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Site 3, Mother, CF+: I got run through they received 
the results, obviously, to the screening test and said 
that one of the ones that came out was the CF gene 
…they said that the CF meant that they wanted me to 
come to hospital the next day and that was basically 
it, really. I think it was, sort of, good to be just blunt 
to the point of ‘Yes, she has it,’ and definitely to come 
in the next day.
Parents who had not experienced the interventions also 
indicated it was useful to have ‘essential information’ and 
‘optional additional information’ separated on the initial 
communication checklist. They felt this would facilitate 
tailoring of information provision during this first contact 
to accommodate parental reactions and how receptive 
they were to the information being provided.
Site 1, Mother, CF–: I’s just down to the individual par-
ent, really, because some will want to know everything 
and some, you know, for me, I couldn’t really speak 
much and I needed to time to, like, digest the infor-
mation so having the hospital appointment the next 
day was just right for us because it gave us a chance to 
think but not long term.
In terms of formatting, similar to the laboratory 
proformas, clinicians felt it would be useful if the check-
lists were on one side of A4.
Clinician 1, Site 2: If it was all on one page, I don’t 
know, it may prompt me to do it more. I think when 
you’re in the flow of conversation, you don’t really 
read, do you? You just kind of know what it says and 
then I don’t really turn the page. So, one page would 
be great.
Once implemented, clinicians also made various recom-
mendations for things that could be added or removed 
from the communication checklists.
Email/letter for parents
Coherence of the intervention
Most clinicians indicated that the email/letter for parents 
following the initial communication of the positive NBS 
result, had been useful to clarify the next steps for parents.
Clinician 2, Site 1: I like the emails, I do think they 
save time and they’re structured professionally—I 
like the fact that it’s in stages, like, ‘This is what we’ve 
found and this is your appointment, what happens 
next?’ and then the links…it just adds a nice touch 
to it.
Despite this, it was infrequently used during the 
implementation. This was possibly due to lack of clarity 
regarding who was responsible for sending the informa-
tion to the family. Therefore, staff felt it would be impor-
tant to clarify who was responsible for completing and 
disseminating the email/letter after the initial communi-
cation of the positive NBS result and regularly checking 
the links contained within still worked.
Clinician 4, Site 3: I think just so we all know what 
our roles are, so we know what responsibility that we 
take, and then if, going back to the email thing, if the 
email is being sent, then yes, who would ask the email 
address?
However, when shared with parents who had expe-
rienced the other interventions, they felt it would have 
been beneficial.
Site 3, Mother, CF+: To have that initial link to the 
website or just to be even told on the phone, you 
know, would be great to help, you know, understand 
and to help pass on the information to my family as 
well because even my parents didn’t know what it was, 
and they Googled it.
These parents also indicated that the additional infor-
mation provided about the hospital visit would have also 
been beneficial.
Site 3, Father, CF+: It does add to the stress of it a lit-
tle bit, if you’ve got to look it up. At least, I suppose, 
if you’ve got all the information there, then that’s 
something less to worry about on the day.
This view was echoed by parents who had not experi-
enced the interventions who suggested that including 
information about why they had been contacted, details 
of when, where and with whom their appointment would 
be with and what would happen during the appointment 
as well as condition specific and reliable information 
sources would have been beneficial.
Site 2, Mother, MCADD–: I’d think, ‘Jesus, how am I 
supposed to do this? What are the logistics of getting 
my child there? Where is it? Where do I park? How 
can I park?’ So, yes, definitely a sheet like, I think, 
that would be extremely helpful.
Furthermore, both parents who had and had not 
experienced the interventions indicated this could have 
reduced their initial anxiety by providing reliable infor-
mation resources. Parents who had experienced the other 
interventions stated due to not having sufficient infor-
mation after receiving their child’s positive NBS result, 
they used other information sources such as Google even 
though they had been advised not to which had added to 
their distress.
Site 3, Mother, CF+: They didn’t really explain to me 
over the phone what it was so obviously I Googled it, 
worst decision ever.
This was also expressed by parents who had not experi-
enced any of the interventions. Again, this was attributed 
to a lack of information provision when the NBS results 
was communicated to them but also fear related to what 
was perceived as a warning about Google:
Site 2, Mother and Father, IVA–: They kind of just 
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it.’ Which left us-, you obviously think, ‘Oh, why not 
Google it? It’s obviously really bad.’
This often led to increased anxiety as the information 
was either inaccurate or out of date. Therefore, both sets 
of parents welcomed the idea of being sent relevant and 
reliable hyperlinks after the initial communication of the 
positive NBS result.
Compatibility and resource use
In terms of compatibility with existing resources, some 
clinicians indicated that the email/letter was similar to 
approaches they already had in place and so did not 
foresee any difficulties with implementing it into prac-
tice. Other felt it represented an improvement on current 
processes in use and could be time saving. However, clini-
cians were concerned about the email/letter following 
communication of the initial positive NBS result meeting 
GDPR requirements.
Clinician 1, Site 1:  NHS. net, is secure, but their email 
isn’t secure. It’s about sending confidential informa-
tion. So, if we’re emailing a parent…we have to send 
an initial email which says, ‘You are consenting to 
sending confidential information through potential-
ly an insecure email.’ We have to get that consent first 
before we send anything over email.
Clinicians were also concerned about the accessibility 
of the interventions, particularly the letter/email for 
parents following communication of a positive NBS result 
in terms of those with language or literacy barriers.
However, most clinicians felt that parents would be able 
to access the links in the email /letter.
Clinician 4, Site 1: I think most of the population 
have got a smartphone that they use to browse, so 
there’s no reason why they can’t click on the links. 
So, I would be surprised if they didn’t have the ability 
to do that.
DISCUSSION
Implementing the interventions in the two study sites 
served to highlight the differences between the efficacy 
and effectiveness of the co- designed interventions30; some 
of the suggestions made during the co- design phase, were 
not fulfilled when implemented in practice. The impact 
of COVID-19 also led to issues with sustained engage-
ment with staff which also hampered the implementation 
phase. This has been explored in more detail overall and 
for each of the co- designed interventions.
Intervention fidelity
Auditing completed proformas in the current study 
revealed that these were only partially implemented; 
only the first page of the double- sided document was 
completed and completion of the first page ranged from 
58%–76%. Completion of the communication checklists 
ranged from 43%–80%. During the co- design phase, 
staff indicated that more detailed information provision 
would be beneficial to improve communication practices. 
However, in practice, feedback suggested that there may 
have been some ambiguity related to who was responsible 
for completing certain sections and evidence of duplica-
tion. Both of these may have acted as barriers to comple-
tion and may have accounted for the lower completion 
rates for certain sections. In addition, limited sustained 
engagement with staff has been identified previously as 
a barrier to standardisation in healthcare.31 32 The level 
of staff engagement during the implementation phase 
differed both within and across study sites which could 
have contributed to this variation in completion rates.
Implementation of the laboratory proforma
Site 1 was served by one NBSL, Sites 2 and 3 were served 
by the other NBSL. Communication of positive NBS 
results starts in the NBSLs who make referrals to clini-
cians who then communicate with parents. Therefore, 
in essence, staff in the NBSLs led the implementation 
of the co- designed interventions. Staff in Site 2 acted as 
champions for the co- designed interventions and even 
expressed the desire to keep using them after the study 
ended. It is known that having a champion to advocate 
for the ‘new way of doing things’32 can lead to interven-
tions being implemented more effectively and this was 
certainly evident in the implementation phase. This also 
highlighted the importance of leadership and the ability 
of perceived leaders to control implementation in terms 
of facilitating or hindering the process. The role of cham-
pions providing leadership in NBS strategies has been 
highlighted previously.33 This emphasises the importance 
of involving key stakeholders such as organisational leads 
and potentially policy- makers in any future studies.
Staff in Site 1 stated they were not aware that different 
referral forms were being used by NBSLs throughout 
the country and therefore the need for the intervention. 
Evidence suggests that when staff are dismissive of the 
evidence, this can reinforce resistance to implementation 
efforts.32 Furthermore, convincing staff that there is a 
problem, and that the proposed solution is appropriate 
has been previously recognised as a barrier to healthcare 
improvement.34 This was further hampered by clinicians 
in this site indicating that certain members of the NBSL 
had instructed others not to use the co- designed inter-
ventions. This was despite the fact that all clinicians who 
participated in implementation had been involved in the 
project from the outset and the perception therefore 
being that they had ‘bought in’ to the aims and objectives 
of the project. However, during implementation, these 
same clinicians acted as gatekeepers as the communica-
tion process started in the NBSL and if this section was 
not completed, it made it more difficult and potentially 
time consuming for the rest of the interventions to be 
completed. Leadership plays a vital role in successful 
implementation of complex interventions and respected 
individuals can play a vital role in encouraging colleagues 
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buy in from what was considered top of the communica-
tion chain for positive NBS results, had the potential to 
hamper the implementation process.
The other sites were aware that different processes 
were being used nationally and felt that standardisa-
tion would be important for many reasons including: 
ease of completion; standardisation of communication; 
and transferability between NBSL. Potential problems 
included compatibility with existing computer systems; 
one site felt it would be preferable if the proforma could 
be automatically populated as this would be time saving 
and reduce the potential for errors. Other studies which 
have also attempted to standardise process in healthcare 
settings have highlighted similar issues. One study which 
attempted to implement a standardised policy for label-
ling of invasive tubing and lines in a UK region found that 
despite being seen as a common sense approach at the 
outset, numerous practical, social and cultural challenges 
hampered implementation.31 Similar to the current study, 
some staff remained unconvinced of the need for the 
change. Furthermore, practical issues which challenged 
pre- existing norms, practices and procedures were also 
found to be a barrier to successful implementation.
Communication of the positive NBS result: communication 
checklists and the email/letter template
Parents in the present study who had and had not expe-
rienced the co- designed checklist indicated that stan-
dardising communication of positive NBS results would 
be preferable to ensure consistency. Some clinicians also 
indicated that standardisation of initial communication 
with parents following a positive NBS result would be 
beneficial. Others felt that standardisation was not always 
possible or desirable as the communication was too 
nuanced and complex. As mentioned previously, studies 
have indicated that parental information needs regarding 
the NBS result were variable, condition specific7 and 
individualised.15 However, other studies have indicated 
that variability in the content and the method used for 
communication can lead to increased parental anxiety 
and distress.4 6
Clinicians who chose to not use the communication 
checklist stated that they had developed their own way 
of doing things and therefore did not see the purpose 
of it. This reiterates the impact of convincing staff that 
there is a problem that needs to be addressed but also 
that the proposed solution is appropriate.34 In addition, 
an organisational culture comprising of staff resistant to 
trial new innovations has been cited as a potential barrier 
to successful implementation of new interventions.32 This 
could have explained the clinicians’ reticence to trial the 
checklist although this was not evident in other clinicians 
within the same team which perhaps suggests it may be 
more personal than organisational.
The objective of the communication checklist was to 
focus on the initial communication of the positive NBS 
result. However, during the co- design phase, clinicians 
and parents chose to develop checklists that included the 
first clinic visit as well as subsequent visits that included 
information about the NBS result, to facilitate commu-
nication between members of the multidisciplinary team 
(MDT). Despite this, when implemented, most staff only 
completed the checklists for the initial communication of 
the positive NBS result; when audited, completion of the 
initial checklist ranged from 43%–80%. Previous reviews 
of the literature have indicated that checklists can facil-
itate communication between MDT members in other 
settings such as cancer35 and intensive care settings.36 
Both sets of parents, that is, those who had and had not 
experienced the co- designed checklist also indicated 
that checklists that covered ongoing communication 
regarding their child’s positive NBS result could facilitate 
pacing and tailoring of information. Quantity and quality 
of the initial communication of the positive NBS result 
has been deemed problematic in previous studies4 12 15 
and suggests that guidance that meets parents needs but 
is also flexible may be preferable.
Regardless of the approach used, the skills and attri-
butes of the person communicating the result was an 
important factor in terms of the communication of posi-
tive NBS results for all parents in the present study regard-
less of whether they had experienced the interventions or 
not. This has been highlighted in previous studies4 11 37 
and demonstrates the value of the interpersonal skills 
of the person communicating the positive NBS results. 
One clinician in the current study stated that these skills 
cannot be captured in any form of guidance or checklist. 
However, other staff felt that the communication check-
lists would be useful training aids for less experienced 
staff. However, it is acknowledged that while the checklists 
can act as a guide, and standardise and facilitate commu-
nication strategies, they cannot teach someone how to 
be empathetic to parental cues in what is undoubtedly a 
highly emotive encounter.
Almost all parents who had received a positive NBS 
result consulted the internet for information about their 
child’s suspected condition even though they had been 
advised not to do so. This is similar to the findings of 
previous studies.6 15 In order to remedy this, an email/
letter outlining next steps and appropriate informa-
tion sources was developed. Parents and staff indicated 
this would be useful to deter parents from accessing 
sites which were outdated and/or inaccurate as well as 
providing information they could share with family and 
friends. However, it was acknowledged that in order for 
this to continue to be successful, it would be vital to clarify 
who would be responsible for checking and updating 
these.
Strengths and limitations
The current study has numerous strengths. This is the 
first known study that has used co- designed interventions 
to improve communication of positive newborn blood-
spot screening results. HCPs involved in the present study 
were employed in three different NHS organisations, 
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included: HCPs involved in managing all nine conditions 
currently included in the NBS programme in England; 
and parents of children diagnosed with one of the nine 
conditions currently included in the NBS programme in 
England; previous work has mainly focused on CF and 
SCD. Members of the PPI advisory group and relevant 
charities contributed to the study design, data collection 
and analysis.
In terms of limitations, HCPs were recruited via email; 
those with a pre- existing interest in this topic may have 
been more likely to self- select into the study. These people 
may communicate results differently than providers who 
did not participate in the study. The researchers are expe-
rienced in this field which may have biased data collec-
tion and analysis. COVID-19 hindered implementation of 
the co- designed interventions and related data collection.
Recommendations for future research and practice
Given the variability in terms of intervention fidelity 
across individuals and sites, further feasibility testing with 
additional sites, staff members and parents to inform and 
refine the interventions prior to a national evaluation 
would be beneficial.
However, the preliminary findings suggest the use of 
standardised, condition specific laboratory proformas 
and checklists for communicating positive NBS results to 
families would ensure that vital information is consistently 
relayed between HCPs and to families thereby reducing 
unnecessary variation. While most study participants 
thought the proformas and checklists were a positive 
improvement to current practice, this was not unanimous 
and several participants highlighted variation in practice 
and potential barriers with implementation. These need 
to be better understood ahead of implementation.
Guidance regarding reliable sources of further infor-
mation for parents would also reduce alarm that can be 
caused by accessing unhelpful content on the internet 
immediately after the initial communication of the posi-
tive NBS result. This might include the use of specifically 
designed applications or other forms of ‘easy to access’ 
and helpful online information for parents. Keeping this 
information up to date can be a laborious task, and if 
done locally this could result in different quality of infor-
mation being shared with parents; one of the main issues 
that the guidance would be trying to avoid.
CONCLUSION
Unjustified variations in communication practices for 
positive NBS screening results continue to exist; these 
have the potential to cause real and repeated harms. 
Implementation of the co- designed interventions demon-
strated that they have the potential to standardised 
communication of positive NBS result from NBSLs to 
clinical teams and then from clinicians to parents; this 
could improve parents’ experience of receiving a positive 
NBS result. Implementation highlighted organisational 
and contextual barriers to effective adoption of the co- de-
signed interventions in practice.
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